26 Feb Atopic Dermatitis – Eczema: Greater Awareness in Black and Hispanic Children
MedicalResearch.com Interview with:
Siri Choragudi
Medical Student University of Miami
Gil Yosipovitch, MD
Professor and Stiefel endowed Chair of Medical Dermatology at the
Dr Phillip Frost Department of Dermatology
Miller School of Medicine at University of Miami
Example of Eczema-Atopic Dermatitis
DermNet NZ Image
MedicalResearch.com: What is the background for this study? Would you briefly describe what is mean by eczema?
Response: There is limited data on prevalence of childhood eczema ( atopic dermatitis) in the US in the last decade. There is evidence that there is an over all increase around the world from 8% to 15%
MedicalResearch.com: What are the main findings? Were there gender, ethnic or socioeconomic differences in the findings?
Example of Eczema-Atopic Dermatitis
DermNet NZ Image
Response: The prevalence of eczema in the US sample increased from 1997 to 2018 (from 7.9% to 12.6%) in all races and age groups There were observed significant disparities between races. Specifically, larger yearly average increases in children with eczema in the Black and multiracial subgroups (compared to white) were identified as well as an increase in Hispanic children around all age groups
MedicalResearch.com: What should readers take away from your report?
Response: Awareness about the high increase of childhood eczema in US almost 60% increase and in particular in Black and Hispanics
MedicalResearch.com: What recommendations do you have for future research as a results of this study?
Response: Better understanding of mechanisms behind this increase whether its higher awareness of diagnosis , environmental factors such living in urban environments or genetic or epigenetic factors and whether this increase in trend can be reduced with life style and preventive measures
Disclosures: Gil Yosipovitch: Abbvie, Arcutis, BMS, Cara Therapuetics, GSK. Escient Health, Eli Lilly, Galderma, Kiniksa Pharmaceuticals, LEO Pharma, Novartis, Pfizer, Pierre Fabre, Regeneron Pharmaceuticals, Inc., Sanofi, TreviTherapeutics, Vifor – advisory board member; Eli Lilly, Kiniksa Pharmaceuticals, LEO Pharma, Novartis, Pfizer, Galderma, Escient, Sanofi Regeneron, Celldex – grants/research funding; Regeneron Pharmaceuticals, Inc., Sanofi – investig
Member of Scientific Board of NEA and IEC member
Siri Choragudi has no COI She is funded by DREAM Award at Miami and PEDRA
Citation:
Choragudi S, Yosipovitch G. Trends in the Prevalence of Eczema Among US Children by Age, Sex, Race, and Ethnicity From 1997 to 2018. JAMA Dermatol. Published online February 22, 2023. doi:10.1001/jamadermatol.2022.6647
The information on MedicalResearch.com is provided for educational purposes only, and is in no way intended to diagnose, cure, or treat any medical or other condition. Always seek the advice of your physician or other qualified health and ask your doctor any questions you may have regarding a medical condition. In addition to all other limitations and disclaimers in this agreement, service provider and its third party providers disclaim any liability or loss in connection with the content provided on this website.
Last Updated on March 1, 2023 by Marie Benz